KN

Kumari Nishikanta

Active Director Director DIN 07085268
DIN 07085268 First appointment Feb 2015 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2015
Shareholding value •••• Premium profile

About Kumari Nishikanta

Data last updated:

Kumari Nishikanta is a Director at Medmax Lab Private Limited (since 2015). The company operates in Trading. Medmax Lab Private Limited reported revenue of ₹7.6 Lakh (FY 2025).

DIN 07085268
Primary Designation Director
Industry Trading
First Appointment 20 Feb 2015
Oldest Company Age 11 yrs
Largest company Medmax Lab Private Limited · ₹7.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medmax Lab Private Limited U24230MP2015PTC033876
Director20 Feb 20152015₹7.6 Lakh (FY 2025)Active

Board colleagues of Kumari Nishikanta

NameDINCompanyDesignation
Mukesh Kumar Singh07085267Medmax Lab Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medmax Lab Private Limited
Premium access

Shareholding and investment profile for Kumari Nishikanta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumari Nishikanta

Kumari Nishikanta currently holds 1 directorship: Medmax Lab Private Limited (Director, since 20 Feb 2015, revenue ₹7.6 Lakh (FY 2025)).

Kumari Nishikanta was first appointed on 20 Feb 2015 as Director at Medmax Lab Private Limited.

The current boards of Kumari Nishikanta's companies include Mukesh Kumar Singh (Medmax Lab Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available